Company: FENC
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001558370-25-011552
Chunk: 3

Company: FENNEC PHARMACEUTICALS INC.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 1F
Chunk 3
---
 145,608​Additional paid-in capital​  69,127​  66,958​Accumulated deficit​  (223,998)​  (219,681)​Accumulated other comprehensive income​  1,243​  1,243​Total stockholders’ deficit​  (7,463)​  (5,872)​Total liabilities and stockholders’ deficit​$ 44,876​$ 44,946​​​​​​​​​

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.